Latest Breaking News On - International business units - Page 1 : comparemela.com

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders

Showcasing wilate® at EAHAD 2024WIL-31 is the largest prospective prophylaxis study in VWD with an on-demand run-in study as an intra-individual patient .

Switzerland generalNordrhein westfalenThromb haemostIvana spotakovaOlaf walterLarisa belyanskayaRobertf sidonio jrHead of international business units at octapharmaSatellite symposiumSenior vice presidentAna bobanCsongor kissPanorama roomBoard memberInternational business unitsFull prescribing information

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

LACHEN, Switzerland, Jan. 18, 2024 /PRNewswire/

Switzerland generalNordrhein westfalenThromb haemostIvana spotakovaLarisa belyanskayaRobertf sidonio jrOlaf walterHead of international business units at octapharmaSatellite symposiumSenior vice presidentAna bobanPanorama roomBoard memberInternational business unitsFull prescribing informationTher adv hematol

Octapharma AG: Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

Octapharma AG: Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenUnited kingdomSwitzerland generalUnited statesSan diegoStefan klotterAntonia follenziRobertf sidonio jrOlaf walterRobert klamrothJoyce kimenaiPaul battyFabrizioa pennacchioLarisa belyanskayaUniversity college londonUniversity of eastern piedmont

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

/PRNewswire/ New clinical data from Octapharma s haematology portfolio will be presented during the scientific program at the 65th American Society of.

United kingdomNordrhein westfalenSan diegoUnited statesSwitzerland generalFabrizioa pennacchioRobert klamrothJoyce kimenaiAntonia follenziLarisa belyanskayaPaul battyRobertf sidonio jrOlaf walterUniversity of eastern piedmontHead of international business units at octapharmaBone health in hemophiliaa patients

Octapharma to present new clinical data and studies at ASH 2022 to demonstrate its continued mission to meet the challenges faced by people with bleeding disorders

/PRNewswire/ New clinical data from Octapharma s haematology portfolio, including the results of the phase 3 WIL-31 study, will be presented during the.

United statesSwitzerland generalNordrhein westfalenSylvia wernerLarisa belyanskayaCraig kesslerOlaf walterThromb haemostRobertf sidonio jrAmerican society of hematologyScientific programHead of international business units at octapharmaAmerican societyBoard memberInternational business unitsPlasma derived antithrombin concentrate